Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10400	Companies
217243	Keywords
146882	Articles
115002	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 03/19/2024 at 09:47, 2 years 1 month ago

Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty
Heidelberg Pharma receives USD 25 million upfront cash payment from HealthCare Royalty for royalty purchase agreement. Funds to advance ADC pipeline development and extend cash runway

Heidelberg Pharma HealthCare Royalty ADC Pipeline Royalty Purchase Agreement Cash Payment
BRIEF

published on 03/18/2024 at 07:30, 2 years 1 month ago

Heidelberg Pharma Advances to Cohort 6 in Multiple Myeloma Study with HDP-101

Heidelberg Pharma HDP-101 Multiple Myeloma Phase I/IIa Study Cohort 6
BRIEF

published on 03/18/2024 at 07:30, 2 years 1 month ago

Heidelberg Pharma passe à la cohorte 6 dans l'étude sur le myélome multiple avec HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple Étude De Phase I/IIa Cohorte 6
PRESS RELEASE

published on 03/18/2024 at 07:25, 2 years 1 month ago

Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
Heidelberg Pharma progresses into Cohort 6 with ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study, showing first objective responses and partial remissions. Amended protocol includes optimized dosing regimens

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study ATAC Candidate Protocol Amendment
PRESS RELEASE

published on 03/07/2024 at 12:27, 2 years 2 months ago

Original-Research: Heidelberg Pharma AG (von EQUITS GmbH): Kaufen
EQUI.TS GmbH bekräftigt Anlageurteil KAUFEN für Heidelberg Pharma AG nach Royalty-Verkauf an HCRx, der die F&E Aktivitäten beschleunigt und das ZircaixTM Potential um 50% steigert

Heidelberg Pharma AG EQUI.TS GmbH Royalty-Verkauf ZircaixTM Potential F&E Aktivitäten
BRIEF

published on 03/06/2024 at 07:51, 2 years 2 months ago

Heidelberg Pharma to Showcase HDP-101 Efficacy and ADC Technology at AACR 2024

Cancer Research Heidelberg Pharma HDP-101 ADC Technology AACR Meeting 2024
BRIEF

published on 03/06/2024 at 07:51, 2 years 2 months ago

Heidelberg Pharma présentera l'efficacité du HDP-101 et la technologie ADC à l'AACR 2024

Recherche Contre Le Cancer Heidelberg Pharma HDP-101 Technologie CAN Réunion AACR 2024
PRESS RELEASE

published on 03/06/2024 at 07:46, 2 years 2 months ago

Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024
Heidelberg Pharma to present first efficacy data on HDP-101 and data from proprietary ADC technology platform at AACR Meeting 2024. Details of ATAC and ADC-based cancer therapies

Clinical Trials Heidelberg Pharma ADC Technology AACR Meeting 2024 ATAC Therapies
BRIEF

published on 03/04/2024 at 11:24, 2 years 2 months ago

Heidelberg Pharma Secures Up to $115 Million in Royalty Financing from HealthCare Royalty

Biopharmaceuticals Heidelberg Pharma HealthCare Royalty Royalty Financing ZircaixTM
BRIEF

published on 03/04/2024 at 11:24, 2 years 2 months ago

Heidelberg Pharma obtient jusqu'à 115 millions de dollars de financement en redevances auprès de HealthCare Royalty

Heidelberg Pharma Redevance En Matière De Soins De Santé Financement Des Redevances ZircaixTM Produits Biopharmaceutiques

Accesswire

Published on 05/13/2026 at 15:30, 47 minutes ago

All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 1 hour 12 minutes ago

Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 1 hour 17 minutes ago

ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 1 hour 17 minutes ago

Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
Published on 05/13/2026 at 14:35, 1 hour 42 minutes ago

INEO Announces Patented INEO Welcoming DUO in Full Production with First Installation Underway in Leading UK Retailer

View all ACCESSWIRE

EQS Group

Published on 05/13/2026 at 16:05, 12 minutes ago

PR Emerges as the Primary Source for Journalists in High-Pressure Newsrooms
Published on 05/13/2026 at 16:05, 12 minutes ago

Coupa and Celonis Collaborate to Eliminate Value Leakage Across Autonomous Spend Management
Published on 05/13/2026 at 15:57, 20 minutes ago

MLP SE: Invitation to the Annual General Meeting of MLP SE published
Published on 05/13/2026 at 15:45, 32 minutes ago

Remission Fund Opens to Compensate Victims of the AirBit Club Fraud
Published on 05/13/2026 at 15:30, 47 minutes ago

Gabler Group AG Invites to Earnings Call on Unaudited Q1 2026 Results

Les Echos

Published on 05/13/2026 at 16:00, 17 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 05/13/2026 at 16:00, 17 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 05/13/2026 at 14:31, 1 hour 46 minutes ago

Statement of transactions in own shares from May 4, 2026 to May 8, 2026
Published on 05/13/2026 at 14:31, 1 hour 46 minutes ago

Déclaration des transactions sur actions propres réalisées du 04/05/2026 au 08/05/2026
Published on 05/13/2026 at 12:27, 3 hours 50 minutes ago

Franchisee Litigation - The Paris Court of Appeal Rules in Favor of Carrefour

View all LES ECHOS COMFI WIRE